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Abstract
Introduction:  Acromegaly  is  a  relatively  rare  chronic  hormonal  disease  resulting  in  disfigure-
ment. In  90%  of  cases,  acromegaly  is  caused  by  a  benign  pituitary  monoclonal  human  growth
hormone-secreting  tumor.  The  aim  of  the  present  study  was  to  determine  the  presence  of  left
ventricular  (LV)  deformation  abnormalities  using  three-dimensional  speckle-tracking  echocar-
diography  in  a  group  of  acromegalic  patients.
Methods:  Thirty-eight  acromegalic  patients  were  involved  in  the  study.  Thirteen  patients
were excluded  due  to  inadequate  image  quality.  The  mean  age  of  the  remaining  patients
was 57.2±13.6  years  and  seven  were  male.  Their  data  were  compared  to  an  age-  and
gender-matched  control  population,  which  consisted  of  34  healthy  volunteers  (mean  age:
52.7±4.9 years,  15  male).
Results:  Global  and  mean  segmental  LV  radial  strain  (RS)  (33.2±13.4%  vs.  25.2±10.8%,  p=0.01
and 36.0±12.1%  vs.  28.2±10.0%,  p=0.009,  respectively)  proved  to  be  significantly  higher
in acromegaly  compared  to  controls.  Active  acromegalic  patients  had  significantly  higherl  LV-RS  (35.5±14.4%  vs.  25.2±10.8%,  p=0.03  and  37.9±13.3%  vs.
ctively)  compared  to  controls.  Between  the  active  and  inactive
sal  LV  circumferential  strain  (-30.2±4.8%  vs.  -26.7±4.1%,  p=0.02)
y  different.global and  mean  segmenta
28.2±10.0%, p=0.03,  respe
acromegaly  groups,  only  ba
was found  to  be  significantl∗ Corresponding author.
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Conclusion:  The  presented  clinical,  demographic,  therapeutic  and  echocardiographic  features
demonstrate  that  active  acromegaly  is  associated  with  enhanced  LV  RS  as  compared  to  healthy
controls and  those  with  inactive  acromegaly.
© 2020  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
PALAVRAS-CHAVE
Acromegalia;
Ecocardiografia;
Func¸ão;
Ventrículo  esquerdo;
Speckle  tracking
tridimensional
Associac¸ão  entre  acromegalia  ativa  e  contractilidade  ventricular  aumentada:
resultados  do  Estudo  MAGYAR-Path  com  ecocardiografia  tridimensional  por  speckle
tracking
Resumo
Introduc¸ão: A  acromegalia  é  uma  doenc¸a  hormonal  crónica  relativamente  rara,  associada  a
dismorfismos  somáticos.  Em  90%  dos  casos,  ela  é  causada  por  um  tumor  benigno  monoclonal
da hipófise,  secretor  de  hormona  do  crescimento.  O  objetivo  do  presente  estudo  foi  dete-
tar a  presenc¸a  de  alterac¸ões  da  deformac¸ão  miocárdica  do  ventrículo  esquerdo  (VE)  através
de ecocardiografia  tridimensional  por  speckle  tracking  num  grupo  de  doentes  portadores  de
acromegalia.
Métodos: Foram  incluídos  38  doentes  portadores  de  acromegalia.  Treze  foram  excluídos  devido
à má  qualidade  de  imagem.  A  idade  média  dos  restantes  foi  de  57,2±13,6  anos  (7  homens).  Os
seus dados  foram  comparados  com  uma  populac¸ão  controlo  emparelhada  por  idade  e  género,
que compreendeu  34  voluntários  saudáveis  (idade  média:  52,7±4,9  anos,  sendo  15  indivíduos
do sexo  masculino).
Resultados:  O  strain  radial  (SR)  global  e  segmentar  VE  (respetivamente  33,2±13,4%  versus
25,2±10,8%, p=0,01  e  36,0±12,1%  versus  28,2±10,0%,  p=0,009)  foi  significativamente  superior
nos casos  de  acromegalia  em  relac¸ão  aos  casos  controlo.  Os  doentes  portadores  de  acrome-
galia ativa  tiveram  um  SR  global  e  segmentar  significativamente  superior  (35,5±14,4%  versus
25,2±10,8%, p=0,03  e  37,9±13,3%  versus  28,2±10,0%,  p=0,03,  respetivamente),  quando  com-
parados com  os  grupos  controlo.  Entre  os  grupos  portadores  de  acromegalia  ativos  e  inativos,
só foi  considerado  significativamente  diferente  o  strain  circunferencial  basal  VE  (-30,2±4,8%
versus  -26,7±4,1%,  p=0,02).
Conclusões:  Com  base  nas  características  clínicas,  demográficas,  terapêuticas  e  ecocardiográ-
ficas apresentadas,  a  acromegalia  ativa  apresenta  SR-VE  aumentado  em  relac¸ão  à  populac¸ão
saudável e  ao  grupo  de  portadores  de  acromegalia  inativa.
© 2020  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este e´ um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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cromegaly  is  a  relatively  rare  chronic  hormonal  disease
esulting  in  disfigurement.  In  90%  of  cases,  acromegaly  is
aused  by  a  benign  pituitary  monoclonal  human  growth
ormone  (HGH)-secreting  tumor.1 Elevation  of  serum
GH  causes  an  elevation  in  insulin-like  growth  factor  1
IGF-1),  and  these  hormonal  changes  cause  a  wide  range
f  clinical  symptoms  and  comorbidities  including  metabolic,
espiratory,  other  endocrine  and  cardiovascular  diseases.2,3
f  these  cardiovascular  comorbidities,  hypertension  and  left
entricular  (LV)  hypertrophy  are  the  most  common,  but
erious  valvular  regurgitation  and  heart  failure  can  also
evelop.  A  higher  incidence  of  cardiac  arrhythmias,  most
ommonly  atrial  fibrillation,  has  frequently  been  reported
n  acromegaly.4,5
Three-dimensional  (3D)  speckle-tracking  echocardiogra-
hy  (STE)  (3D-STE)  is  a  new,  non-invasive,  robust  and
p
i
w
walidated  tool  offering  clinicians  a  new  imaging  modality.
D-STE  is  capable  of  measuring  various  global,  segmental
nd  regional  strain  values  through  LV  modeling.6,7 To  the
est  of  the  authors’  knowledge,  there  have  been  no  3D-
TE  studies  on  LV  deformation  abnormalities  in  acromegaly.
herefore,  the  aim  of  the  present  study  was  to  determine
he  presence  of  LV  deformational  abnormalities  using  3D-STE
n  a  group  of  acromegalic  patients.
ethods
atient  population
hirty-eight  acromegalic  patients  were  included  in  the
resent  study.  Thirteen  were  excluded  due  to  inadequate
mage  quality.  The  mean  age  of  the  remaining  patients
as  57.2±13.6  years  and  seven  were  male.  Their  data
ere  compared  to  an  age-  and  gender-matched  control
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population,  which  consisted  of  34  healthy  volunteers  (mean
age  52.7±4.9  years,  15  male).  The  diagnosis  of  acromegaly
was  based  on  current  clinical  standards:  typical  clinical
features,  elevated  HGH  levels,  and  elevated  IGF-1  levels
insuppressible  with  an  oral  glucose  tolerance  test.5 The
acromegalic  group  was  further  divided  based  on  the  activ-
ity  of  the  disease:  if  serum  HGH  and/or  IGF-1  concentration
was  over  the  diagnostic  threshold,  acromegaly  was  consid-
ered  to  be  active.5,8 Our  study  was  approved  by  the  human
research  ethics  committee  of  our  institution  and  complied
with  the  Declaration  of  Helsinki.  All  of  the  patients  and
healthy  volunteers  gave  informed  consent.  Our  acromegalic
datasets  came  from  the  MAGYAR-Path  Study  (Motion  Analysis
of  the  heart  and  Great  vessels  bY  three-dimensionAl  speckle-
tRacking  echocardiography  in  Pathological  cases),  which  was
developed  to  assess  the  diagnostic  and  prognostic  value  of
3D-STE-derived  parameters  (‘Magyar’  means  ‘Hungarian’  in
the  Hungarian  language).
Two-dimensional  Doppler  and  tissue  Doppler
echocardiographyAll  healthy  volunteers  and  acromegalic  patients  underwent
a  complete  two-dimensional  (2D)  transthoracic  echocar-
diographic  study  using  a  Toshiba  ArtidaTM imaging  system
T
c
t
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Figure  1  Three-dimensional  speckle-tracking  echocardiographic  s
apical 2-chamber  view  (B)  are  automatically  selected  by  the  softwar
(C5) and  basal  (C7)  left  ventricular  (LV)  levels.  The  three-dimension
(E) are  shown  along  with  segmental  LV  radial  strain  curves  (F).191
Toshiba  Medical  Systems,  Tokyo,  Japan)  with  a  PST-30SBP
hased-array  transducer  (1-5  MHz).  The  examinations  were
erformed  according  to  current  clinical  standards.  In  all
ases  LV  dimensions,  volumes  and  ejection  fraction  (LVEF)
nd  left  atrial  (LA)  dimensions  were  measured  and  complete
D  Doppler  and  tissue  Doppler  studies  were  performed.9
hree-dimensional  speckle-tracking
chocardiography
or  the  3D-STE  examinations,  the  same  Toshiba  ArtidaTM sys-
em  was  used,  with  a  PST-25SX  matrix-  array  transducer
Toshiba  Medical  Systems,  Tokyo,  Japan).7 In each  case,  a
yramid-shaped  full-volume  3D  dataset  was  obtained.  The
omplete  dataset  consisted  of  six  wedge-shaped  subvol-
mes,  which  were  recorded  during  six  RR  intervals  and  a
ingle  breath-hold.  The  subvolumes  were  set  to  be  as  nar-
ow  as  possible  to  improve  spatial  resolution,  thus  improving
ater  endocardial  border  delineation.  The  recorded  datasets
ere  analyzed  offline  using  the  supplied  3D  Wall  Motion
racking  software,  version  2.7  (Toshiba  Medical  Systems,
okyo,  Japan).  From  the  datasets,  the  software  automati-
ally  reconstructed  apical  4-chamber  and  2-chamber  views,
hen  the  reader  specified  the  three  cross-sectional  planes
anually,  using  the  guide  planes  to  help  standardize  LV
tudy  of  an  acromegalic  patient.  Apical  4-chamber  view  (A)  and
e.  Cross-sectional  planes  are  at  the  apical  (C3),  midventricular
al  LV  model  (D)  and  the  corresponding  volumetric  parameters
1m
s
l
d
(
T
e
v
3
(
b
T
e
a
3
c
t
(
n
c
m
c
b
a
S
A
n
S
b
t
d
p
d
c
T
v
l92  
easurements.  After  setting  up  the  planes,  the  reader  then
pecified  the  septal  and  lateral  parts  of  the  mitral  annu-
us  and  the  LV  apex,  after  which  the  software  automatically
etected  the  endocardial  border  and  created  a  3D  LV  cast
Figure  1).
hree-dimensional  speckle-tracking
chocardiography-derived  left  ventricular
olumetric  measurements
D-STE  was  used  to  measure  LV  end-diastolic  volume
LVEDV),  LV  end-systolic  volume  (LVESV),  LVEF  and  LV  mass
ased  on  the  above-mentioned  LV  cast.
hree-dimensional  speckle-tracking
chocardiography-derived  left  ventricular  strain
ssessments
D-STE  strain  measurements  were  performed  on  the  LV
ast  using  the  16-segment  LV  model.10 In  each  segment,
hree  unidirectional  strain  parameters  were  assessed:  radial
RS)  (thickening  and  thinning  of  the  segment),  longitudi-
al  (LS)  (lengthening  and  shortening  of  the  segment)  and
(
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Table  1  Demographic,  clinical  and  two-dimensional  echocardio
controls.
Controls  (n=34)  
Risk  factors
Age,  years  52.7±4.9  
Male gender,  %  15  (44)  
BSA, m2 1.87±0.23  
Hypertension,  %  0  (0)  
Hypercholesterolemia,  %  0  (0)  
Diabetes, %  0  (0)  
Hypophysectomy,  %  0  (0)  
2D echocardiography
LA diameter,  mm  38.8±4.4  
LA diameter/BSA,  mm/m2 20.7±2.6  
LA volume,  ml  48.8±16.5  
LA volume/BSA,  ml/m2 24.1±8.1  
LVEDD, mm  47.7±3.3  
LVEDD/BSA,  mm/m2 25.8±3.1  
LVEDV, ml  107.0±20.3  
LVEDV/BSA,  ml/m2 58.6±9.8  
LVESD, mm  31.6±3.0  
LVESD/BSA,  mm/m2 17.0±2.6  
LVESV, ml  37.7±9.0  
LVESV/BSA,  ml/m2 19.1±6.3  
IVS, mm  9.4±1.3  
LV posterior  wall,  mm  9.6±1.6  
E, cm/s  71.5±18.9  
A, cm/s  70.3±18.0  
E/A 1.06±0.31  
LVEF, %  64.5±3.6  
2D: two-dimensional; A: late transmitral flow velocity; BSA: body surf
septal thickness; LA: left atrial; LV: left ventricular; LVEDD: left ventric
volume; LVEF: left ventricular ejection fraction; LVESD: left ventricular eÁ.  Kormányos  et  al.
ircumferential  (CS)  (widening  and  narrowing  of  the  seg-
ent).  Based  on  these  strain  parameters,  the  software
alculated  the  following  complex  strains:  area  (AS)  (com-
ination  of  LS  and  CS)  and  3D  (3DS)  (combination  of  RS,  LS
nd  CS).
tatistical  analysis
ll  data  are  reported  as  mean  ±  standard  deviation.  Sig-
ificance  was  established  for  p  values  less  than  0.05.  The
hapiro-Wilks  test  was  used  to  check  for  normal  distri-
ution.  Levene’s  test  for  equality  of  variances  was  used
o  test  homogeneity  of  variance.  For  normally  distributed
atasets,  the  two-tailed  Student’s  t  test  was  used  for  com-
arisons,  however  if  the  dataset  did  not  follow  a  normal
istribution,  the  Mann-Whitney-Wilcoxon  test  was  used.  For
ategorical  variables,  Fisher’s  exact  test  was  performed.
o  establish  significant  relationships  between  independent
ariables,  Pearson’s  correlation  coefficients  were  calcu-
ated.  The  statistical  analysis  was  performed  using  RStudio
RStudio  Team,  RStudio:  Integrated  Development  for  R.
Studio,  Inc.,  Boston,  MA,  2015).  For  offline  data  extrac-
ion  and  analysis,  a  commercial  software  package  was  used
MATLAB  8.6,  The  MathWorks  Inc.,  Natick,  MA,  2015).
graphic  characteristics  of  patients  with  acromegaly  and  of
Acromegalic  patients  (n=25)  p
57.2±13.6  0.07
7  (28)  0.27
2.05±0.29  0.01
15  (60)  <0.0001
12  (48)  <0.0001
5  (20)  0.01
9  (36)  0.0002
42.2±6.1  0.02
20.6±3.2  0.9
54.1±18.0  0.4
28.5±9.5  0.8
51.3±5.3  0.006
25.6±4.2  0.9
129.9±28.7  0.002
64.9±16.5  0.1
31.6±4.7  0.95
15.9±2.6  0.2
41.9±14.7  0.2
21.3±6.8  0.3
10.3±1.6  0.02
10.8±1.8  0.007
65.3±14.0  0.3
79.3±16.1  0.05
0.85±0.21  0.004
67.6±7.2  0.1
ace area; E: early transmitral flow velocity; IVS: interventricular
ular end-diastolic diameter; LVEDV: left ventricular end-diastolic
nd-systolic diameter; LVESV: left ventricular end-systolic volume.
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Results
Clinical  and  demographic  characteristics  of
patients with  acromegaly
Significant  differences  were  identified  between  acromegalic
patients  and  healthy  controls  regarding  the  prevalence  of
hypertension  (p<0.0001),  hypercholesterolemia  (p<0.0001)
and  diabetes  (p=0.01)  (Table  1).
Laboratory  findings  of  patients  with  acromegaly
The  active  acromegaly  subgroup  consisted  of  14  patients
(mean  age:  58.6±14.6  years,  five  males).  Their  mean  serum
HGH  level  was  5.5±3.9  ng/ml,  IGF-1  level  was  502.3±366.0
ng/ml  and  IGF-1  index  (IGF-1  level/upper  limit  of  nor-
mal)  was  2.0±1.1.  The  inactive  acromegaly  group  included
11  patients  (mean  age:  54.0±12.9,  2  males).  Their  mean
serum  HGH  level  was  4.5±8.1  ng/ml,  IGF-1  level  was
216.9±129.0  ng/ml  and  IGF-1  index  was  0.9±0.6.
Two-dimensional  echocardiographic  data
Significant  differences  were  seen  in  LA  diameter  (p=0.02),
LV  end-diastolic  diameter  (LVEDD)  (p=0.006)  and  vol-
ume  (LVEDV)  (p=0.002),  interventricular  septal  thickness
(p=0.02),  and  LV  posterior  wall  thickness  (p=0.007)  between
the  acromegalic  group  and  healthy  controls.  Body  surface
area  (BSA)  was  also  significantly  different  between  controls
and  acromegalic  patients  (p=0.01).  Furthermore,  late  trans-
mitral  flow  velocity  A(p=0.05)  and  E/A  ratio  (p=0.004)  also
differed  significantly  between  the  two  groups  (Table  1).
Three-dimensional  speckle-tracking
echocardiography-derived  left  ventricular
volumetric  parameters
3D-STE-derived  LVEDV  (p=0.0003)  and  LVESV  (p=0.005)
proved  to  be  significantly  different  between  all  the
acromegalic  patients  and  controls.  LVEDV  (p=0.006)  and
LVEF  (p=0.02)  differed  significantly  between  the  active
acromegaly  subgroup  and  controls,  while  LVEDV  (p=0.01)
and  LVESV  (p=0.01)  were  significantly  different  between
the  inactive  disease  subgroup  and  controls.  LVEF  (p=0.02)
was  significantly  higher  in  active  than  in  inactive  disease
(Tables  2  and  3).
Three-dimensional  speckle-tracking
echocardiography-derived  left  ventricular  strain
parameters
Global  and  mean  segmental  RS  (p=0.01  and  p=0.009,  respec-
tively)  were  significantly  higher  in  acromegalic  patients
compared  to  controls.  Among  regional  strain  parameters,
basal  and  apical  RS  (p=0.04  and  p=0.0004,  respectively)
were  significantly  different  between  acromegalic  patients
and  controls.  Patients  with  active  disease  had  significantly
higher  global  and  mean  segmental  RS  (p=0.03  and  p=0.03,
respectively)  compared  to  controls;  in  addition,  basal  and
n
g
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pical  RS  (p=0.04  and  p=0.002,  respectively)  and  basal  CS
p=0.01)  were  significantly  higher  compared  to  controls.  In
atients  with  inactive  disease,  no  significant  differences
ere  detected  in  LV  strain  parameters  compared  to  the  con-
rol  group.  Between  active  and  inactive  disease  groups,  only
asal  CS  (p=0.02)  was  found  to  be  significantly  different
Tables  2  and  3).
orrelation  between  hormone  levels
nd three-dimensional  speckle-tracking
chocardiography-derived  left  ventricular
olumetric  and  strain  parameters
n  the  overall  acromegaly  group,  there  was  a  significant
egative  correlation  between  HGH  levels  and  apical  3DS
r=-0.40,  p=0.05).  No  significant  correlation  was  detected
etween  any  hormone  level  and  LV  strains  in  the  active
isease  group.  In  the  inactive  disease  group,  IGF-1  index
orrelated  significantly  with  midventricular  RS  (r=0.60,
=0.05),  global  and  mean  segmental  RS  (r=0.66,  p=0.03
nd  r=0.66,  p=0.03,  respectively)  and  global  3DS  (r=0.61,
=0.05).  Furthermore,  there  was  a  significant  correlation
etween  mean  segmental  RS  and  IGF-1  levels  (r=0.61,
=0.05)  in  this  group.
iscussion
cromegaly  is  a  severe  chronic  hormonal  disease  that  can
ffect  almost  any  organ  system  through  elevated  HGH  and
GF-1  levels.  These  effects  are  especially  marked  in  the
ardiovascular  system,  resulting  in  numerous  cardiovascular
omorbidities,  the  most  common  of  which  is  hypertension.
lthough  the  pathophysiology  is  not  fully  understood,  it
s  hypothesised  that  circulatory  volume  increases  due  to
odium  retention  and  consequent  plasma  expansion.11--13
urthermore,  acromegaly  is  associated  with  cardiomyopa-
hy,  resulting  in  severe  heart  failure  in  terminal  stages.
n  the  early  stages  of  acromegaly,  LV  hypertrophy  devel-
ps  due  to  exposure  to  elevated  serum  HGH  levels.  As
cromegalic  cardiomyopathy  develops,  Ca2+ hypersensitivity
nhances  myocardial  contractility,  resulting  in  a  hyper-
inetic  syndrome.  As  it  progresses,  LV  hypertrophy  may
ecome  sufficiently  severe  to  impair  LV  diastolic  filling.  In
he  terminal  stages,  both  systolic  and  diastolic  function  may
ecrease  due  to  extracellular  collagen  deposition.14--17 In
ddition,  valvular  regurgitation  and  arrhythmias  are  more
ommon  among  acromegalic  patients.18,19
In  the  present  study,  3D-STE  was  used  to  assess  global  and
egional  LV  strain  parameters  in  acromegalic  patients.  Strain
maging  using  3D-STE  has  been  validated  in  comparisons
ith  two-dimensional  speckle-tracking  echocardiography
2D-STE),  cardiac  magnetic  resonance  imaging  and  tissue
oppler  imaging.6,10,20--22 It  has  been  reported  that  3D-STE-
erived  LV  strain  values  are  somewhat  lower  than  those  from
D-STE.6 Notable  advantages  of  this  method  compared  to
ther  modalities  are  its  non-invasive  nature,  angle  indepen-
ence,  possibility  of  3D  imaging  and  lower  cost.10To  the  best  of  the  authors’  knowledge,  there  have  been
o  3D-STE  studies  on  LV  strain  parameters  in  the  acrome-
alic  population.  There  has  been  only  one  study  which  used
D-STE  to  assess  global  LV  longitudinal  strain  in  patients
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Table  2  Comparison  of  three-dimensional  speckle-tracking  echocardiography-derived  global  and  mean  segmental  left  ventric-
ular peak  strain  parameters  between  acromegalic  patients  and  controls.
Controls  (n=34)  Acromegalic  patients  (n=25)  Active  disease  (n=14)  Inactive  disease  (n=11)
3D-STE-derived  volumetric  parameters
LVEDV,  ml  80.5±20.2  107.6±28.9a 108.5±34.6a 101.1±23.3a
LVESV,  ml  34.9±10.6  45.4±14.9a 43.7±17.7  45.3±12.7a
LVEF,  %  56.7±7.1  58.1±6.1  60.2±5.8a,b 55.6±5.8
Global strains
Radial,  %  25.2±10.8  33.2±13.4a 35.5±14.4a 29.7±11.3
Circumferential,  %  -26.7±6.1  -28.1±4.5  -29.3±4.1  -27.0±4.9
Longitudinal,  % -16.0±2.7  -15.8±3.4  -15.5±3.1  -16.1±3.9
3D, % 27.6±10.7 31.3±11.8 32.5±13.8 29.1±8.3
Area,  % -39.3±5.8 -39.9±5.2 -40.8±4.7 -39.3±6.0
Mean  segmental  strains
Radial,  %  28.2±10.0  36.0±12.1a 37.9±13.3a 33.1±9.9
CS, %  -28.1±5.9  -29.1±4.3  -30.3±4.1  -28.2±4.4
LS, %  -16.9±2.6  -17.0±3.4  -16.7±3.0  -17.5±4.0
3DS, %  30.2±9.8  33.7±10.8  34.6±12.5  31.6±7.6
AS, %  -40.4±5.6  -41.2±5.3  -42.1±4.7  -40.6±6.1
a p<0.05 vs. controls.
b p<0.05 vs. inactive disease.
3D: three-dimensional; 3D-STE: three-dimensional speckle-tracking echocardiography; 3DS: three-dimensional strain; AS: area strain; CS:
circumferential strain; LS: longitudinal strain; LVEDV: end-diastolic volume, LVESV: end-systolic volume, LVEF: left ventricular ejection
fraction; RS: radial strain.
Table  3  Comparison  of  three-dimensional  speckle-tracking  echocardiography-derived  regional  left  ventricular  peak  strain
parameters between  acromegalic  patients  and  controls.
Controls  (n=34)  Acromegalic  patients  (n=25)  Active  disease  (n=14)  Inactive  disease  (n=11)
RS  basal,  %  34.3±14.8  44.6±19.2a 46.9±20.7a 40.2±16.8
RS mid,  %  29.6±12.1  34.6±12.8  35.8±14.2  32.1±10.1
RS apex,  %  16.9±8.3  25.6±10.1a 27.9±10.6a 23.9±10.4
CS basal,  %  -26.1±5.8  -28.9±4.9  -30.2±4.8a,b -26.7±4.1
CS mid,  %  -28.4±7.4  -28.5±5.0  -29.3±5.1  -27.8±5.2
CS apex,  %  -30.6±12.6  -30.6±10.0  -31.7±9.2  -31.1±9.7
LS basal,  %  -20.8±5.0  -19.1±5.5  -18.3±6.1  -19.3±4.4
LS mid  %)  -13.6±4.1  -14.7±3.6  -15.0±2.9  -15.0±4.7
LS apex,  %  -16.0±5.5  -17.3±7.7  -16.9±8.7  -18.4±6.4
3DS basal,  %  37.1±13.9  44.3±17.4  45.9±19.5  40.7±13.9
3DS mid,  %  30.7±11.9  30.3±12.5  31.2±14.2  28.1±9.1
3DS apex,  %  19.2±9.3  21.8±10.8  23.0±10.9  21.5±11.4
AS basal,  % -40.6±6.8  -41.6±7.1  -42.0±7.8  -40.0±5.5
AS mid,  %  -38.8±7.5  -39.0±6.2  -40.4±5.4  -38.3±7.5
AS apex,  % -42.7±14.4  -43.8±12.8  -44.6±12.2  -45.0±12.5
a p<0.05 vs. controls.
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3DS: three-dimensional strain; AS: area strain; CS: circumferentia
ith  active  acromegaly,  by  Volschan  et  al.,  who  reported  no
ignificant  differences  in  global  LV-LS  compared  to  healthy
ontrols.23 Our  group  has  previously  reported  increased  aor-
ic  stiffness  in  acromegaly  as  well  as  reduced  LV  rotation
nd  twist  in  both  active  and  inactive  acromegaly.  It  could
e  hypothesized  that  these  changes  are  the  consequences
f  extracellular  collagen  deposition.24,25
Results  of  the  2D  echocardiography  study  in  our  pop-
lation  showed  that  in  patients  with  acromegaly,  the  LV
c
t
s
din; LS: longitudinal strain; RS: radial strain.
as  dilated,  LV  walls  were  significantly  thicker  and  there
as  impaired  LV  diastolic  function  without  LV  systolic
ysfunction.  Of  the  3D-STE-derived  LV  volumetric  parame-
ers,  LVEDV  was  significantly  increased  regardless  of  disease
ctivity.  In  patients  with  active  acromegaly,  LVEF  was  higher
ompared  to  the  control  group,  and  was  significantly  higher
han  in  the  inactive  acromegaly  group.  Global  and  mean
egmental  LV-RS  were  significantly  higher  in  cases  of  active
isease  compared  to  both  the  healthy  controls  and  those
CT
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1Left  ventricular  contractility  in  acromegaly  
with  inactive  disease.  It  should  be  noted  that  LV  strain  val-
ues  were  normal  in  patients  with  inactive  acromegaly.  Based
on  these  findings,  it  could  be  hypothesized  that  enhanced
regional  strain  may  be  a  compensatory  mechanism  offsetting
the  impaired  LV  rotation  and  twist  demonstrated  recently.25
Our  results  suggest  that  LV  deformation  differences  are
reversible  with  proper  treatment,  but  not  LV  dilation.  Fur-
ther  investigations  are  warranted  to  assess  why  LV  rotation
and  twist  are  impaired  but  LV  wall  contractility  is  not.  In
addition,  LV-RS  appears  to  compensate  for  the  loss  of  LV
twist.
Limitations
There  are  several  limitations  affecting  the  present  study.
Since  acromegaly  is  a  rare  disease,  the  study  population  is
relatively  small.  The  duration  of  exposure  to  high  serum  HGH
and  IGF-1  concentrations  was  not  taken  into  account  in  the
analysis,  and  the  possible  effects  of  drugs  used  in  the  treat-
ment  of  acromegaly  were  not  examined.  3D-STE  as  a  novel
modality  suffers  from  several  limiting  technical  factors:  it
has  lower  spatial  and  temporal  resolution  than  2D-STE,  and
the  full-volume  dataset  requires  six  identical  RR  intervals,
which  can  result  in  so-called  stitching  noise.26 It  has  also
been  reported  that  LV  strain  parameters  show  some  vendor
dependency.27 Finally,  the  greater  proportion  of  women  in
the  control  group  could  partially  explain  differences  in  heart
dimensions  between  the  groups.
Conclusion
The  presented  clinical,  demographic,  therapeutic  and
echocardiographic  features  demonstrate  that  active
acromegaly  is  associated  with  enhanced  LV-RS  as  compared
to  healthy  controls  and  those  with  inactive  acromegaly.
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